Cargando…

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas

BACKGROUND: Diffuse gliomas, grades II and III, hereafter called lower-grade gliomas (LGG), have variable, difficult to predict clinical courses, resulting in multiple studies to identify prognostic biomarkers. The purpose of this study was to assess expression or methylation of the homeobox family...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yu-An, Zhou, Yunyun, Luo, Xin, Song, Kai, Ma, Xiaotu, Sathe, Adwait, Girard, Luc, Xiao, Guanghua, Gazdar, Adi F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264450/ https://www.ncbi.nlm.nih.gov/pubmed/27840009 http://dx.doi.org/10.1016/j.ebiom.2016.10.040

Ejemplares similares

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain
por: Parisot, Sarah, et al.
Publicado: (2016)

Current therapeutic approaches to diffuse grade II and III gliomas
por: Picca, Alberto, et al.
Publicado: (2018)

Variants in the 5′UTR reduce SHOX expression and contribute to SHOX haploinsufficiency
por: Babu, Deepak, et al.
Publicado: (2020)

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

Expressing human SHOX in Shox2(SHOX KI)/(KI) mice leads to congenital osteoarthritis-like disease of the temporomandibular joint in postnatal mice
por: Liang, Wenna, et al.
Publicado: (2016)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
por: Wu, Xiaocong, et al.
Publicado: (2023)

Profiling of conserved non-coding elements upstream of SHOX and functional characterisation of the SHOX cis-regulatory landscape
por: Verdin, Hannah, et al.
Publicado: (2015)

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
por: Zhang, Zhen-Yu, et al.
Publicado: (2015)

Skeletal Deformity Associated with SHOX Deficiency
por: Seki, Atsuhito, et al.
Publicado: (2014)

Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
por: Choi, Jinhyun, et al.
Publicado: (2020)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

Evaluation of the 7(th) and 8(th) editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort
por: Yang, Lin, et al.
Publicado: (2017)

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
por: Binder, H., et al.
Publicado: (2019)

Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network
por: Darlix, Amélie, et al.
Publicado: (2019)

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
por: Chen, Yanming, et al.
Publicado: (2021)

Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas
por: Zhang, Zhaogang, et al.
Publicado: (2022)

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
por: Wu, Gang, et al.
Publicado: (2014)

Islet1 is a direct transcriptional target of the homeodomain transcription factor Shox2 and rescues the Shox2-mediated bradycardia
por: Hoffmann, Sandra, et al.
Publicado: (2013)

Multi-parametric arterial spin labelling and diffusion-weighted magnetic resonance imaging in differentiation of grade II and grade III gliomas
por: Razek, Ahmed Abdel Khalek Abdel, et al.
Publicado: (2020)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
por: Martinez-Velez, Naiara, et al.
Publicado: (2019)

Importance of evaluating health-related quality of life issues in survivors of WHO grade II or III gliomas
por: Dirven, Linda
Publicado: (2022)

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging
por: Liu, Sirui, et al.
Publicado: (2022)

Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation
por: Delgado, Anna F., et al.
Publicado: (2017)

Rare and de novo duplications containing SHOX in clubfoot
por: Sadler, Brooke, et al.
Publicado: (2020)

shox2 is required for vestibular statoacoustic neuron development
por: Laureano, Alejandra S., et al.
Publicado: (2023)

Genetic Analysis and Sonography Characteristics in Fetus with SHOX Haploinsufficiency
por: Li, Lushan, et al.
Publicado: (2023)

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis
por: Thust, S. C., et al.
Publicado: (2018)

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
por: Bernhardt, Denise, et al.
Publicado: (2020)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

Much debated controversies of diffuse low-grade gliomas
por: Zadeh, Gelareh, et al.
Publicado: (2015)

Impact of the revised WHO classification of diffuse low-grade glioma on clinical decision making: A case report
por: van der Vlis, Tim A. M. Bouwens, et al.
Publicado: (2017)

The Short-Stature Homeobox-Containing Gene (shox/SHOX) Is Required for the Regulation of Cell Proliferation and Bone Differentiation in Zebrafish Embryo and Human Mesenchymal Stem Cells
por: Yokokura, Tomoaki, et al.
Publicado: (2017)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
por: Steidl, Eike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvt6gpdmqpr160oq8osi85sqjr